Wustrow D J, Capiris T, Rubin R, Knobelsdorf J A, Akunne H, Davis M D, MacKenzie R, Pugsley T A, Zoski K T, Heffner T G, Wise L D
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2067-70. doi: 10.1016/s0960-894x(98)00372-2.
A series of 3-phenylpyrazolo[1,5-a]pyrimidines was prepared and found to have affinity for the human CRF-1 receptor. The 3-dimensional structure of one of the most potent analogs in this series, 10d, was determined by X-ray crystallography and suggests the spatial requirements for potent CRF-1 receptor binding affinity in this series.
制备了一系列3-苯基吡唑并[1,5-a]嘧啶,并发现它们对人CRF-1受体具有亲和力。通过X射线晶体学确定了该系列中最有效的类似物之一10d的三维结构,并揭示了该系列中对CRF-1受体具有强效结合亲和力的空间要求。